||
复发/难治性外周T细胞淋巴瘤有望迎来新选择
https://www.ebiotrade.com/newsf/2024-1/20240104064739549.htm
(3701)
(2242)
(1359)
(770)
(685)
(594)
(539)
(497)
(481)
(474)
(469)
(462)
(330)
(330)
(302)
(298)
(219)
(215)
(211)
(199)
http://www.pubmedplus.cn/P/SearchQuickResult?wd=d4d525e9-df06-4e26-a4b7-30550a2046c5
01. | Lymphoma | 422 篇 | 100.000% |
02. | Humans | 389 篇 | 92.180% |
03. | Retrospective Studies | 77 篇 | 18.246% |
04. | Male | 62 篇 | 14.692% |
05. | Female | 58 篇 | 13.744% |
06. | Adult | 53 篇 | 12.559% |
07. | Animals | 50 篇 | 11.848% |
08. | Antineoplastic Combined Chemotherapy Protocols | 36 篇 | 8.531% |
09. | Aged | 34 篇 | 8.057% |
10. | Middle Aged | 33 篇 | 7.820% |
Archiver|手机版|科学网 ( 京ICP备07017567号-12 )
GMT+8, 2024-5-16 00:50
Powered by ScienceNet.cn
Copyright © 2007- 中国科学报社